Arrowroot Family Office’s iShares Biotechnology ETF IBB Stock Holding History

Arrowroot Family Office’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	8,951 +262	+3%	+$45K	0.49%	48
2026 Q1	$1.47M	Sell	8,689 -2,145	-20%	-$367K	0.49%	48
2025 Q4	$1.83M	Sell	10,834 -1,244	-10%	-$202K	0.67%	38
2025 Q3	$1.74M	Buy	12,078 +741	+7%	+$101K	0.7%	35
2025 Q2	$1.43M	Buy	+11,337	New	+$1.39M	0.64%	41
2024 Q4	$1.51M	Buy	11,395 +4,354	+62%	+$612K	0.78%	32
2024 Q3	$1.03M	Buy	7,041 +1,921	+38%	+$278K	0.6%	44
2024 Q2	$703K	Sell	5,120 -102	-2%	-$13.6K	0.45%	57
2024 Q1	$717K	Sell	5,222 -54	-1%	-$7.38K	0.46%	57
2023 Q4	$717K	Sell	5,276 -1,459	-22%	-$178K	0.51%	53
2023 Q3	$824K	Buy	6,735 +756	+13%	+$96.1K	0.65%	47
2023 Q2	$759K	Buy	5,979 +2,414	+68%	+$314K	0.57%	50
2023 Q1	$460K	Buy	+3,565	New	+$467K	0.39%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Arrowroot Family Office's IBB Position: Q2 2026 in Review

Arrowroot Family Office increased its iShares Biotechnology ETF (IBB) stake by 3% in Q2 2026, buying an estimated $45K and bringing the position to 8,951 shares worth $1.7M. The position accounts for 0.49% of the portfolio, ranked #48.

Arrowroot Family Office first reported a position in IBB in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.83M in Q4 2025. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Arrowroot Family Office held 8,951 shares of iShares Biotechnology ETF worth $1.7M as of Q2 2026.
Arrowroot Family Office bought 262 iShares Biotechnology ETF shares in Q2 2026, an estimated $45K.
iShares Biotechnology ETF made up 0.49% of Arrowroot Family Office's portfolio in Q2 2026, its #48 holding.
Arrowroot Family Office first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 13 quarters since.
Arrowroot Family Office's iShares Biotechnology ETF position peaked at $1.83M in Q4 2025.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Arrowroot Family Office's 13F filing for Q2 2026, filed 6 Aug 2026.